Pembrolizumab
Merck
['keytruda', 'nsclc', 'lung', 'sclc', 'pembro', 'merck', '$mrk']
five-year data for #mercks #keytruda (#pembrolizumab) plus #chemotherapy showed sustained survival benefit versus chemotherapy alone in two studies for #metastatic #nonsmallcelllungcancer (#nsclc) #esmo22 $mrk 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.